AG00IA1I

56238-63-2 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-

Chemical structure of 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-, CAS 56238-63-2
AG00IA1I
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 56238-63-2
Catalog Number AG00IA1I(AGN-PC-0SL384)
Chemical Name 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
EC Number 260-073-1
IUPAC Name sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI InChI=1S/C16H16N4O8S.Na/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20;/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24);/q;+1/p-1/b19-9-;/t10-,14-;/m1./s1
InChI Key URDOHUPGIOGTKV-JTBFTWTJSA-M
MDL Number MFCD09878727
Molecular Formula C16H15N4NaO8S
Molecular Weight 446.3671
SMILES O=C([O-])C(N1[C@]([H])([C@@H](C1=O)NC(/C(C2=CC=CO2)=NOC)=O)SC3)=C3COC(N)=O.[Na+]
UNII R8A7M9MY61
Synonyms
Cefuroxime, Cephuroxime, Ketocef, Zinacef, CEFUROXIME SODIUM, Cefuroxime sodium salt, Anaptivan, Biociclin, Sodium cefuroxime, Zinacef, Colifossim, Curoxima, Curoxime, Spectrazolr, Ultroxim, Bioxima, Cefofix, Cefumax, Cefurex, Curocef, Curoxim, Furoxil, Kesint, Ketocef, Lifurox, Medoxim, Cefuroxim Hexal, Cefuroxim Lilly, Cefuroxima Fabra, Cefuroxim AJ, Cefuroxim MN, 56238-63-2, Cefuroxim curasan, Cefuroxima Richet, Cetroxil [inj.], Cefuroxim Fresenius, Cefuroxim Genericsn, Froxal [inj.], Sharox [inj.], Zinnat [inj.], Cefuroxim Norcox [inj.], Kefurox, Cefuroxime (sodium), Sharox, KEFUROX IN PLASTIC CONTAINER, ZINACEF IN PLASTIC CONTAINER, UNII-R8A7M9MY61, EINECS 260-073-1, CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CHEBI:3517, R8A7M9MY61, Cefuroxime for Injection and Dextrose for Injection in Duplex Container, Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester), Cetroxil, Froxal, Cefuroxim Norcox, Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, cefuroxime na, cefuroximesodium, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt (6R-(6alpha,7beta(Z)))-, Zinacef (TN), Cefuroxime sodium [USAN:BAN:JAN], CXM, Biofurex, Cefurin, Novocef, Duxima, MLS000069576, Cefuroxime sodium [USP:BAN:JAN], sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, KS-1040, SMR000058808, MLS001332625, MLS001332626, C16H15N4O8S.Na, Cefuroxime sodium (JAN/USP), SCHEMBL719536, CHEMBL2146124, HMS2097O21, HMS3714O21, HY-B1256, s4620, AKOS015961772, CCG-220720, CS-4733, AC-15028, AN-40200, BC208459, LS-149936, C08108, D00915, Cefuroxime sodium, European Pharmacopoeia (EP) Reference Standard, Cefuroxime sodium, United States Pharmacopeia (USP) Reference Standard, (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, (6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-, sodium (6R,7R)-3-(carbamoyloxymethyl)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, cefuroxime, Zinnat, Biofuroksym, Cefuroximine, Cefuroximo, Cefuroximum, Cephuroxime, Cefuroxim, Cefuril, Cefurox, Cefur, Zinacef Danmark, Cefuroxime (TN), Ceftin (TN), Zinnat (TN), SODIUM, Cefuroxime (USAN/INN), Cefuroximum [INN-Latin], Cefuroximo [INN-Spanish], D0Y2IE, C16H15N4NaO8S, C16H16N4O8S.Na, Cefuroxime [USAN:INN:BAN], Cefuroxime sodium (JP15/USP), Cefuroxime sodium salt - 1G 1g, C16-H15-N4-O8-S.Na, ACN-039969, CID6523269, 55268-75-2, (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester), 3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, [6R-[6.alpha.,7.beta.(Z)]]-, Sodium [6R-[6alpha,7beta(Z)]]-3-[[(aminocarbonyl)oxy]methyl]-7-[2-furyl(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited